Serous Carcinoma
Research from University of Toronto provide new insights into serous carcinoma
Published in Women's Health Weekly, October 9th, 2008
"To update the data on the expression of 'mesothelioma markers' by serous carcinomas of various sites we have studied cases from ovary (n = 56), endometrium (n = 37), fallopian tube (n = 6), primary peritoneum (n = 5) and cervix (n = 3) using a panel of antibodies (WT1, P53, estrogen receptors, HER2/neu, D2-40, cytokeratin 5/6 and E-cadherin). Ovarian carcinomas demonstrated D2-40 and cytokeratin 5/6 immunoreactivity in 23.2 and 55.4% of cases, respectively," scientists in Toronto, Canada report.
"Endometrial carcinomas demonstrated D2-40 and cytokeratin 5/6 immunoreactivity in 43.2 and 37.8% of cases, respectively. D2-40 staining pattern was predominantly focal;...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- American Psychological Association
Sexism pays: Study finds men who hold traditional views of women earn more than men who don't - BioMed Central
Exercise effective in helping pregnant women kick the habit - Canadian Medical Association Journal
Over 1 in 4 South African men report using physical violence against their female partners - JAMA and Archives Journals
Black patients at higher risk for colon polyps - Journal of the National Cancer Institute
New model predicts relapse in early breast cancer patients following endocrine therapy - Journal of the National Cancer Institute
Observational study suggests hormone therapy safe for postmenopausal BRCA mutation carriers - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
